Synergistic reactivation of latent HIV expression by ingenol-3-angelate, PEP005, targeted NF-kB signaling in combination with JQ1 induced p-TEFb activation

G Jiang, EA Mendes, P Kaiser, DP Wong, Y Tang… - PLoS …, 2015 - journals.plos.org
Although anti-retroviral therapy (ART) is highly effective in suppressing HIV replication, it
fails to eradicate the virus from HIV-infected individuals. Stable latent HIV reservoirs are …

Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ–NF-κB signaling

G Jiang, EA Mendes, P Kaiser, S Sankaran-Walters… - Aids, 2014 - journals.lww.com
Objective: Although HAART effectively suppresses viral replication, it fails to eradicate latent
viral reservoirs. The 'shock and kill'strategy involves the activation of HIV from latent …

[HTML][HTML] Reactivation of latent HIV-1 by new semi-synthetic ingenol esters

DP José, K Bartholomeeusen, RD da Cunha… - Virology, 2014 - Elsevier
The ability of HIV to establish long-lived latent infection is mainly due to transcriptional
silencing of viral genome in resting memory T lymphocytes. Here, we show that new semi …

The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb

P Lu, X Qu, Y Shen, Z Jiang, P Wang, H Zeng, H Ji… - Scientific reports, 2016 - nature.com
None of the currently used anti-HIV-1 agents can effectively eliminate latent HIV-1
reservoirs, which is a major hurdle to a complete cure for AIDS. We report here that a novel …

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B …

G Darcis, A Kula, S Bouchat, K Fujinaga… - PLoS …, 2015 - journals.plos.org
The persistence of latently infected cells in patients under combinatory antiretroviral therapy
(cART) is a major hurdle to HIV-1 eradication. Strategies to purge these reservoirs are …

Targeting NF-κB signaling with protein kinase C agonists as an emerging strategy for combating HIV latency

G Jiang, S Dandekar - AIDS research and human retroviruses, 2015 - liebertpub.com
Highly active antiretroviral therapy (HAART) is very effective in suppressing HIV-1 replication
and restoring immune functions in HIV-infected individuals. However, it fails to eradicate the …

BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency

P Lu, Y Shen, H Yang, Y Wang, Z Jiang, X Yang… - Scientific Reports, 2017 - nature.com
Persistent latent reservoir in resting CD4+ T cells is a major obstacle in curing HIV-1
infection. Effective strategies for eradication of the HIV-1 reservoir are urgently needed. We …

Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4+ T Cells from Aviremic Patients

AM Spivak, A Bosque, AH Balch, D Smyth… - Antimicrobial agents …, 2015 - Am Soc Microbiol
The human immunodeficiency virus type 1 (HIV-1) latent reservoir in resting CD4+ T cells
represents a major barrier to viral eradication. Small compounds capable of latency reversal …

[HTML][HTML] Reactivation of HIV-1 from latency by an ingenol derivative from Euphorbia kansui

P Wang, P Lu, X Qu, Y Shen, H Zeng, X Zhu, Y Zhu… - Scientific reports, 2017 - nature.com
Cells harboring latent HIV-1 pose a major obstacle to eradication of the virus. The 'shock
and kill'strategy has been broadly explored to purge the latent reservoir; however, none of …

Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy

P Chugh, B Bradel-Tretheway, CMR Monteiro-Filho… - Retrovirology, 2008 - Springer
Abstract Background Unlike CD4+ T cells, HIV-1 infected macrophages exhibit extended life
span even upon stress, consistent with their in vivo role as long-lived HIV-1 reservoirs …